301 related articles for article (PubMed ID: 37830586)
21. PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition.
Zhou W; Jubb AM; Lyle K; Xiao Q; Ong CC; Desai R; Fu L; Gnad F; Song Q; Haverty PM; Aust D; Grützmann R; Romero M; Totpal K; Neve RM; Yan Y; Forrest WF; Wang Y; Raja R; Pilarsky C; de Jesus-Acosta A; Belvin M; Friedman LS; Merchant M; Jaffee EM; Zheng L; Koeppen H; Hoeflich KP
J Pathol; 2014 Dec; 234(4):502-13. PubMed ID: 25074413
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological inhibition of Rac1-PAK1 axis restores tamoxifen sensitivity in human resistant breast cancer cells.
Gonzalez N; Cardama GA; Comin MJ; Segatori VI; Pifano M; Alonso DF; Gomez DE; Menna PL
Cell Signal; 2017 Jan; 30():154-161. PubMed ID: 27939839
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional regulation of ataxia-telangiectasia and Rad3-related protein by activated p21-activated kinase-1 protects keratinocytes in UV-B-induced premalignant skin lesions.
Beesetti S; Mavuluri J; Surabhi RP; Oberyszyn TM; Tober K; Pitani RS; Joseph LD; Venkatraman G; Rayala SK
Oncogene; 2017 Nov; 36(44):6154-6163. PubMed ID: 28692051
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-induced acetylation of PAK1 enhances autophagy and promotes brain tumorigenesis via phosphorylating ATG5.
Feng X; Zhang H; Meng L; Song H; Zhou Q; Qu C; Zhao P; Li Q; Zou C; Liu X; Zhang Z
Autophagy; 2021 Mar; 17(3):723-742. PubMed ID: 32186433
[TBL] [Abstract][Full Text] [Related]
25. Cytoplasmic P120ctn Promotes Gefitinib Resistance in Lung Cancer Cells by Activating PAK1 and ERK Pathway.
Liu WW; Hu J; Wang R; Han Q; Liu Y; Wang S
Appl Immunohistochem Mol Morphol; 2021 Nov-Dec 01; 29(10):750-758. PubMed ID: 34412070
[TBL] [Abstract][Full Text] [Related]
26. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
27. 1,2,3-Triazolyl ester of Ketorolac: A "Click Chemistry"-based highly potent PAK1-blocking cancer-killer.
Nguyen BCQ; Takahashi H; Uto Y; Shahinozzaman MD; Tawata S; Maruta H
Eur J Med Chem; 2017 Jan; 126():270-276. PubMed ID: 27889630
[TBL] [Abstract][Full Text] [Related]
28. p21-Activated kinase 1 (PAK1) in aging and longevity: An overview.
Amirthalingam M; Palanisamy S; Tawata S
Ageing Res Rev; 2021 Nov; 71():101443. PubMed ID: 34390849
[TBL] [Abstract][Full Text] [Related]
29. Klotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinoma.
Chen L; Liu H; Liu J; Zhu Y; Xu L; He H; Zhang H; Wang S; Wu Q; Liu W; Liu Y; Pan D; Ren S; Xu J; Gu J
PLoS One; 2013; 8(3):e58413. PubMed ID: 23516476
[TBL] [Abstract][Full Text] [Related]
30. Anti-cancer effect of novel PAK1 inhibitor via induction of PUMA-mediated cell death and p21-mediated cell cycle arrest.
Woo TG; Yoon MH; Hong SD; Choi J; Ha NC; Sun H; Park BJ
Oncotarget; 2017 Apr; 8(14):23690-23701. PubMed ID: 28423593
[TBL] [Abstract][Full Text] [Related]
31. β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation.
Liu JS; Che XM; Chang S; Qiu GL; He SC; Fan L; Zhao W; Zhang ZL; Wang SF
World J Gastroenterol; 2015 Sep; 21(34):9945-56. PubMed ID: 26379399
[TBL] [Abstract][Full Text] [Related]
32. Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells.
Parvathy M; Sreeja S; Kumar R; Pillai MR
BMC Cancer; 2016 May; 16 Suppl 1(Suppl 1):293. PubMed ID: 27229476
[TBL] [Abstract][Full Text] [Related]
33. Stimulus-dependent regulation of the phagocyte NADPH oxidase by a VAV1, Rac1, and PAK1 signaling axis.
Roepstorff K; Rasmussen I; Sawada M; Cudre-Maroux C; Salmon P; Bokoch G; van Deurs B; Vilhardt F
J Biol Chem; 2008 Mar; 283(12):7983-93. PubMed ID: 18160398
[TBL] [Abstract][Full Text] [Related]
34. RAC1 as a Therapeutic Target in Malignant Melanoma.
Cannon AC; Uribe-Alvarez C; Chernoff J
Trends Cancer; 2020 Jun; 6(6):478-488. PubMed ID: 32460002
[TBL] [Abstract][Full Text] [Related]
35. Expression and function of the kallikrein-related peptidase 6 in the human melanoma microenvironment.
Krenzer S; Peterziel H; Mauch C; Blaber SI; Blaber M; Angel P; Hess J
J Invest Dermatol; 2011 Nov; 131(11):2281-8. PubMed ID: 21753781
[TBL] [Abstract][Full Text] [Related]
36. Nuclear factor of activated T cells c1 mediates p21-activated kinase 1 activation in the modulation of chemokine-induced human aortic smooth muscle cell F-actin stress fiber formation, migration, and proliferation and injury-induced vascular wall remodeling.
Kundumani-Sridharan V; Singh NK; Kumar S; Gadepalli R; Rao GN
J Biol Chem; 2013 Jul; 288(30):22150-62. PubMed ID: 23737530
[TBL] [Abstract][Full Text] [Related]
37. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
Al-Azayzih A; Gao F; Somanath PR
Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
[TBL] [Abstract][Full Text] [Related]
38. PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions.
Grebeňová D; Holoubek A; Röselová P; Obr A; Brodská B; Kuželová K
Sci Rep; 2019 Nov; 9(1):17171. PubMed ID: 31748572
[TBL] [Abstract][Full Text] [Related]
39. Effect of increased expression of both ras-related C3 botulinum toxin substrate 1 and p21-activated kinase 1 in patients with N0M0 upper urinary tract urothelial carcinoma and cancer-free surgical margins.
Kuroda K; Asano T; Horiguchi A; Ito K
Jpn J Clin Oncol; 2020 Apr; 50(4):465-472. PubMed ID: 32134451
[TBL] [Abstract][Full Text] [Related]
40. p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma.
Zhu Y; Liu H; Xu L; An H; Liu W; Liu Y; Lin Z; Xu J
Cell Death Dis; 2015 Feb; 6(2):e1637. PubMed ID: 25675297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
